(Q33834203)

English

Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington's disease, Alzheimer's disease and parkinsonism

scientific article published in January 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington's disease, Alzheimer's disease and parkinsonism (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Huntington's disease

0 references

Alzheimer's disease

0 references

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

parkinsonian syndrome

1 reference

based on heuristic

inferred from title

Russel J Reiter

1

object named as

Reiter RJ

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Rosa María Sainz

1 reference

ORCID Public Data File 2021

author name string

Cabrera J

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sainz RM

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Mayo JC

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Manchester LC

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Tan DX

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

1 January 1999

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Annals of the New York Academy of Sciences

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

890

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

471-485

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Blood-brain barrier integrity in Alzheimer's disease patients and elderly control subjects.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

Oxygen toxicity, oxygen radicals, transition metals and disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

A radical hypothesis for neurodegeneration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

Melatonin is a scavenger of peroxynitrite

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

Pharmacological actions of melatonin in oxygen radical pathophysiology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

Potent protective effect of melatonin on chromium(VI)-induced DNA single-strand breaks, cytotoxicity, and lipid peroxidation in primary cultures of rat hepatocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

Melatonin stimulates brain glutathione peroxidase activity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

Oxygen free radicals, melatonin, and aging

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

Rhythms of glutathione peroxidase and glutathione reductase in brain of chick and their inhibition by light.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

Melatonin enhances tamoxifen's ability to prevent the reduction in microsomal membrane fluidity induced by lipid peroxidation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

Neuroprotective potential of aromatic alcohols against oxidative cell death

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

Excitotoxic injury of the neostriatum: a model for Huntington's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

Chemical pathology of Huntington's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

The excitotoxin quinolinic acid is present in the brain of several mammals and its cortical content increases during the aging process

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

Studies on the disposition of quinolinic acid after intracerebral or systemic administration in the rat

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

Melatonin plays a protective role in quinolinic acid-induced neurotoxicity in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

Melatonin affords protection against kainate-induced in vitro lipid peroxidation in brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

Protective effect of melatonin against hippocampal DNA damage induced by intraperitoneal administration of kainate to rats.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

Melatonin protects hippocampal neurons in vivo against kainic acid-induced damage in mice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

Inhibition of Alzheimer beta-fibrillogenesis by melatonin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

An investigation into the role of reactive oxygen species in the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity using neuronal cell lines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

Melatonin is protective against MPTP-induced striatal and hippocampal lesions.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

Melatonin rescues dopamine neurons from cell death in tissue culture models of oxidative stress.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

Glutathione Peroxidase Protects against Peroxynitrite-mediated Oxidations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB08028.X

21 January 2018

Identifiers

10.1111/J.1749-6632.1999.TB08028.X

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33834203&oldid=1631993905"